[PDF][PDF] Expressions of SNCG in gastric adenocarcinoma and its clinical significances

SHI Li-fang, Z Shu-fang2A, Z Yong-gang… - Prog Mod …, 2011 - biomed.cnjournals.com
… the expressions of SNCG in gastric adenocarcinoma, to evaluate … of gastric adenocarcinoma
and 40 cases of normal gastric … cases of gastric adenocarcinoma 15 cases of normal gastric

[PDF][PDF] Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer

YN Chen, Y Gu - Chin J Cancer, 2009 - researchgate.net
… VEGFD and VEGFR3 expression in gastric adenocarcinoma was an independent prognostic
indicator. In addition, VEGFD was also regarded as an independent indicator of poor …

[PDF][PDF] Network pharmacology of medicinal attributes and functions of Chinese herbal medicines:(I) Basic statistics of medicinal attributes and functions for more than …

WJ Zhang - Network Pharmacology, 2017 - researchgate.net
… of network, cancer-related mutations will mostly appear in the genes of specific signaling
pathways. Thus for diagnosis and treatment of cancer and other complex diseases, the target is …

晚期胃癌化疗及分子靶向治疗研究进展

高丹丹, 刘磊, 白玉贤 - 中国肿瘤临床, 2012 - cjco.cn
… the focus of the comprehensive treatment. Chemotherapy combined targeted therapy have
shown great benefit and perspective in treatment of advanced gastric cancer, but their usage …

阿帕替尼治疗恶性肿瘤的临床研究进展

涂艳, 彭枫 - 中国肿瘤临床, 2016 - cjco.cn
… including non-small cell lung cancer, breast cancer, and gastric cancer. Apatinib was approved
… -line treatment for patients with advanced gastric cancer. Apatinib is currently undergoing …

胃癌免疫治疗困境与未来方向.

于园园, 孟千皓, 王广雨 - Practical Oncology Journal, 2021 - search.ebscohost.com
… of gastric cancer. This article reviews the research progress of immunotherapy for advanced
gastric cancer, and elaborates the current … for gastric cancer. [ABSTRACT FROM AUTHOR] …

抗EGFR 家族靶向药物在胃癌治疗中的研究进展

秦军伟, 韩宇, 白玉贤 - 临床肿瘤学杂志, 2014 - manu65.magtech.com.cn
… Advances of anti⁃EGFR family targeted drugs in the treatment of gastric cancer QIN
Junwei,HAN Yu,BAI Yuxian. Department of Medical Digestion,Cancer Hospital,Harbin Medical …

[HTML][HTML] 呋喹替尼FRUTIGA 研究登陆医学顶刊《 Nature Medicine》, 秦叔逵教授深入解读临床意义

E Profile, Q Shukui - laitimes.com
… In the field of gastric cancer, only molecularly targeted drugs targeting HER-2 and
VEGFR have been approved for marketing at home and abroad, but the proportion of HER-2-positive …

[引用][C] Screen and identification of monoclonal antibody against pancreatic cancer stem cells

S Lixin, Y Long, X Yibin, M Wenxiu, L Huiqi, Y Zhihua… - JOURNAL OF MODERN …, 2014

[引用][C] 阿帕替尼治疗胃癌及其他肿瘤的研究现状

赵鹏飞, 曹邦伟 - 临床与病理杂志, 2017